Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and develop new treatments, diagnostics, and preventative methods for specific and complex conditions.

Who May Be Eligible (Plain English)

Who May Qualify: - Persons 18 to 85 years of age at the date of willing to sign a consent form. - If presenting with a history of a specific condition, the diagnosis is confirmable in the medical record or may be confirmed using other forms of verification including self-reporting. - Understands the procedures and requirements of the study by providing written willing to sign a consent form (or verbal assent if a legally authorized representative will sign the ICF), including consent for authorization for protected health information disclosure. Who Should NOT Join This Trial: - Persons younger than 18 years of age or older than 85 years of age at the date of willing to sign a consent form. - Receipt of blood products 30 days before the study blood draw. - Receipt of an investigational (unapproved) drug 30 days before the study blood draw. - A confirmable diagnosis of any medical condition that would increase potential phlebotomy risks. - Has donated a unit of blood within the last 2 months at the date of willing to sign a consent form. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Persons 18 to 85 years of age at the date of informed consent. * If presenting with a history of a specific condition, the diagnosis is confirmable in the medical record or may be confirmed using other forms of verification including self-reporting. * Understands the procedures and requirements of the study by providing written informed consent (or verbal assent if a legally authorized representative will sign the ICF), including consent for authorization for protected health information disclosure. Exclusion Criteria: * Persons younger than 18 years of age or older than 85 years of age at the date of informed consent. * Receipt of blood products 30 days before the study blood draw. * Receipt of an investigational (unapproved) drug 30 days before the study blood draw. * A confirmable diagnosis of any medical condition that would increase potential phlebotomy risks. * Has donated a unit of blood within the last 2 months at the date of informed consent.

Treatments Being Tested

DIAGNOSTIC_TEST

Specimen sample

The study may require a tissue collection and/or a participant survey for participation. Most tissue collected will come from a blood draw; up to 100mL for the health condition group, 60mL for the exceptive condition group, and up to 180mL for the control group (if determined safe for the participant). Participant surveys may involve participant reported outcomes (PROs) or custom participant surveys.

Locations (1)

Sanguine Biosciences
Waltham, Massachusetts, United States